Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 35Gastrointestinal 24Thoracic 8Tumor-Agnostic 7Gynecologic 7Head & Neck 6Other hematologic neoplasm 5Genitourinary 5Lymphoid 2Endocrine 2Sarcoma 1Plasma cell 1Other solid neoplasm 1Other neoplasm 1Other 1NET 1Dermatologic 1Classical hematology 1CNS 1

Conditions

Keratosis, Actinic 1Disease 1

Interventions

Blood Specimen Collection 16Cyclophosphamide 11fludarabine phosphate 10Peripheral Blood Stem Cell Transplantation 10Cyclosporine 10Photochemotherapy 9Biopsy 9Whole-Body Irradiation 8Standard of Care 8Radiotherapy 8Educational Status 8Surgical Procedures, Operative 7Radiosurgery 7Mycophenolic Acid 7Early Intervention, Educational 7Aminolevulinic Acid 7Tomography, Optical Coherence 6Surveys and Questionnaires 6Psychiatric Rehabilitation 6Practice Guidelines as Topic 6Methods 6Melphalan 6Filgrastim 6Busulfan 5Antilymphocyte Serum 5methyl 5-aminolevulinate 4Therapeutics 4Sentinel Lymph Node Biopsy 4Mohs Surgery 4Microscopy, Confocal 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Control Groups × Dermatologic × Clear all
NCT07335003 2026-01-12

Study of the Photoprotection and Prevention of Actinic Damage With Anthelios Fluide 100 KA+ UVMune 400 in Patients With Multiple Actinic Keratoses

Cosmetique Active International

Phase NA Recruiting
80 enrolled
Dermatologic

Disease, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡